Search Results

Filter Results

Reset filters

Date

All Dates

Past 7 Days 5

Past 30 Days 11

Past year 153

Custom range

Custom Date Range

Start date: End date:

Topic

All Topics

Public Health 791

Health Industry 787

Cost and Quality 671

States 664

Insurance 469

Health Care Costs 437

Pharmaceuticals 377

Medicare 370

The Health Law 363

Medicaid 268

Multimedia 243

California 234

Aging 206

COVID-19 167

Mental Health 160

Courts 153

Noticias En Español 122

Rural Health 99

Uninsured 95

Elections 88

Race and Health 54

Global Health Watch 50

Navigating Aging 23

KFF Health News On Air 13

Medi-Cal 11

HealthBent 8

Covered California 7

Postcards 5

KFF Health News Impact 3

Asking Never Hurts 2

The New Old Age 1

Content Type

All Content Types

Morning Briefing 1,337

Podcast 62

Story 1,422

Showing 421-440 of 2,881 results for ""

Sort by Relevance Date

New FDA-Approved Hemophilia Gene Therapy Is World’s Priciest Medicine

November 23, 2022 Morning Briefing

Drugmaker CSL Bering says the $3.5 million price tag for its Hemgenix treatment is justified because it would ultimately reduce long-term health care costs associated with treating patients living with hemophilia B.

X
Facebook
LinkedIn
Email
Print

What the Health? From KFF Health News: All About the (Government) Funding

January 11, 2024 Podcast

With days to go until a large chunk of the federal government runs out of money needed to keep it operating, Congress is still struggling to find a compromise spending plan. Meanwhile, the Supreme Court agreed to hear — this year — a case that pits federal requirements for emergency treatment against state abortion bans. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Tami Luhby of CNN join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews American Medical Association President Jesse Ehrenfeld about the choppy waters facing the nation’s physicians in 2024.

X
Facebook
LinkedIn
Email
Print

Kaiser Permanente’s Third Quarter Finances Show $1.5B Loss

November 7, 2022 Morning Briefing

Meanwhile, a financially-troubled Mississippi hospital failed to reach a deal with a medical campus that was planning to take over the facility, AP reports. In other news, Microsoft has an AI tool that transcribes doctor-patient discussions, at the expense of sharing sensitive info with tech giants.

X
Facebook
LinkedIn
Email
Print

What the Health? From KFF Health News: Alabama’s IVF Ruling Still Making Waves

February 29, 2024 Podcast

Lawmakers in Congress and state legislatures are scrambling to react to the ruling by the Alabama Supreme Court that frozen embryos created for in vitro fertilization are legally children. Abortion opponents are divided among themselves, with some supporting full “personhood” for fertilized eggs, while others support IVF as a moral way to have children. Rachel Cohrs of Stat, Riley Griffin of Bloomberg News, and Joanne Kenen of the Johns Hopkins University schools of nursing and public health and Politico Magazine join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews University of Pittsburgh law professor Greer Donley, who explains how a 150-year-old anti-vice law that’s still on the books could be used to ban abortion nationwide. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.

X
Facebook
LinkedIn
Email
Print

What the Health? From KFF Health News: 2023 Is a Wrap

December 21, 2023 Podcast

2023 was another busy year in health care. As the covid-19 pandemic waned, policymakers looked anew at long-standing obstacles to obtaining and paying for care in the nation’s health care system. Meanwhile, abortion has continued to be an issue in much of the nation, as states respond to the Supreme Court’s 2022 decision overturning the constitutional right to the procedure. This week, Rachel Cohrs of Stat, Sandhya Raman of CQ Roll Call, and Joanne Kenen of Johns Hopkins University and Politico Magazine join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and wrap up the year in health. Also this week, Rovner interviews KFF Health News’ Jordan Rau about his joint KFF Health News-New York Times series “Dying Broke.”

X
Facebook
LinkedIn
Email
Print

KHN’s ‘What the Health?’: Boosting Confusion

November 18, 2021 KFF Health News Original

Federal health officials appear poised to extend a recommendation for covid boosters to all adults, following moves by some governors and mayors to broaden the eligible booster pool as caseloads rise. Meanwhile, the Food and Drug Administration finally has a nominee to head the agency: former FDA chief Robert Califf. And Medicare premiums for consumers will likely rise substantially in 2022, partly due to the approval of a controversial drug to treat Alzheimer’s disease. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann, host of the “An Arm and a Leg” podcast.

X
Facebook
LinkedIn
Email
Print

Birdie is seen standing in front of a sign in her spa that reads, "Mama Bird Maternity Wellness Spa."

Grupos de base lideran el camino para cerrar la brecha de mortalidad infantil en Colorado

By Rae Ellen Bichell June 10, 2022 KFF Health News Original

Aunque Colorado se encuentra entre los estados más saludables del país, las disparidades en salud entre distintos grupos raciales y étnicos son visibles. Y un indicador clave es la mortalidad infantil.

X
Facebook
LinkedIn
Email
Print

What the Health? From KFF Health News: On Abortion Rights, Ohio Is the New Kansas

August 10, 2023 Podcast

Nearly a year to the day after Kansas voters surprised the nation by defeating an anti-abortion ballot question, Ohio voters defeated a similar, if cagier, effort to limit access in that state. This week, they rejected an effort to raise the threshold for approval of future ballot measures from a simple majority, which would have made it harder to protect abortion access with yet another ballot question come November. Meanwhile, the number of Americans without health insurance has dropped to an all-time low, though few noticed. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Roubein of The Washington Post, and Emmarie Huetteman of KFF Health News join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews Kate McEvoy, executive director of the National Association of Medicaid Directors, about how the “Medicaid unwinding” is going, as millions have their eligibility for coverage rechecked.

X
Facebook
LinkedIn
Email
Print

Covid-19 at-home rapid test kits are seen on a shelf at a Walmart Neighborhood Market in Orlando, Florida.

¿Por qué Medicare no paga por las pruebas caseras para covid?

By Michelle Andrews January 24, 2022 KFF Health News Original

Las mismas leyes del programa para los adultos mayores previenen que puedan comprar medicamentos de venta libre y obtener este tipo de pruebas sin una orden médica.

X
Facebook
LinkedIn
Email
Print

Conservative Justices Seem Poised to Overturn Roe’s Abortion Rights

By Julie Rovner December 1, 2021 KFF Health News Original

A majority of the members of the Supreme Court seemed sympathetic Wednesday during arguments to Mississippi’s assertion that the landmark Roe v. Wade decision, which legalized the procedure throughout the country, was wrongly decided.

X
Facebook
LinkedIn
Email
Print

La catarata de información sobre la inscripción a Medicare no explica bien las opciones de Medigap

By Harris Meyer November 9, 2021 KFF Health News Original

En parte porque las políticas sobre el acceso y los costos de Medigap cambian dependiendo del estado, o por la información confusa, muchos beneficiarios no eligen lo que más les conviene.

X
Facebook
LinkedIn
Email
Print

Patent Battle Over Generic Versions Of Gilead HIV Drug Settled

September 13, 2022 Morning Briefing

Five drugmakers had proposed generic versions of Gilead’s HIV and hepatitis B drugs and are now licensed to sell them from around 2031 onward. Also in the news: Medicare advantage star ratings, and more.

X
Facebook
LinkedIn
Email
Print

US Will Spend Over $2B To Back White House Biomanufacturing Plan

September 15, 2022 Morning Briefing

The plan, outlined with new details Wednesday, is about expanding drug manufacturing capabilities in the U.S., with an eye on future pandemic responses. Meanwhile, Roll Call notes “pandemic fatigue” may threaten funding efforts in the battle against monkeypox. The polio outbreak is also reported.

X
Facebook
LinkedIn
Email
Print

Readers and Tweeters Weigh In on Medical Debt, the Obesity Epidemic, and Opioid Battles

June 24, 2022 KFF Health News Original

KHN gives readers a chance to comment on a recent batch of stories.

X
Facebook
LinkedIn
Email
Print

Judge: HHS Must Restore Full 340B Drug Payments Until 2023

September 30, 2022 Morning Briefing

Modern Healthcare reports on a decision from District of Columbia Judge Rudolph Contreras, who found that a Health and Human Services Department lower reimbursement rate was “defective.” Meanwhile, Michigan joins efforts to crimp costs from contract travel nurses.

X
Facebook
LinkedIn
Email
Print

Study Predicts Over 50% More Deaths From Liver Cancer By 2040

October 7, 2022 Morning Briefing

Analysis suggests cases of Hepatitis B and C, more alcohol usage, higher body weight, and more diabetes will be to blame. Separately, a slight drop in food poisonings from salmonella and listeria is reported, but pandemic restrictions are thought to have played a part in the fall.

X
Facebook
LinkedIn
Email
Print

West Virginia Sen. Manchin Takes the Teeth Out of Democrats’ Plan for Seniors’ Dental Care

By Phil Galewitz December 10, 2021 KFF Health News Original

In West Virginia, older residents often go without dental care, and a quarter of people 65 and older have no natural teeth, the highest rate of any state in the country. But a powerful senator from West Virginia, Joe Manchin, has rebuffed efforts to add a dental benefit to Medicare.

X
Facebook
LinkedIn
Email
Print

White House: It Could Take $7B To Combat Monkeypox

July 27, 2022 Morning Briefing

The nearly $7 billion estimate was presented to President Joe Biden as one of a number of different options to fund federal mitigation efforts. Meanwhile, the U.S. now has more monkeypox cases than anywhere else, and the first case in a pregnant woman has been reported.

X
Facebook
LinkedIn
Email
Print

Two photos are shown side by side. The left is of a young woman playing a clarinet at a concert. The right is of the same woman showing her misaligned teeth.

Este dispositivo dental debía arreglar las mandíbulas de los pacientes. Las demandas afirman que les destrozó los dientes

By Brett Kelman and Anna Werner, CBS News March 9, 2023 KFF Health News Original

A los pocos meses de usar AGGA, una paciente dijo que sus dientes estaban tan flojos que podía sentir cómo se movían cuando se untaba crema hidratante en las mejillas. Besar a su novio le resultaba incómodo.

X
Facebook
LinkedIn
Email
Print

A screenshot of the three-person Zoom panel. From clockwise, the speakers are: Céline Gounder, Bill Foege, and Helene Gayle.

Watch: Thinking Big in Public Health, Inspired by the End of Smallpox

September 18, 2023 KFF Health News Original

A conversation about how the lessons from the victory over smallpox could be applied to public health challenges today.

X
Facebook
LinkedIn
Email
Print

More From KFF Health News

A photo of a laptop screen with Facebook Ad Library open. It shows three ads by Medicare Advantage Majority.

Medicare Advantage ‘Dark Money’ Group Attempts To Win Higher Payments for Insurance Companies

Journalists Talk Medicaid Work Mandate in Georgia and Wage Garnishment Bill in Colorado

Doctors Warn of a Deadly Complication From Measles Outbreaks

Sheldon Ekirch walks along a street in her neighborhood.

Families Scramble To Pay Five-Figure Bills as Clock Ticks on Promised Preauthorization Reforms